Is Premature Hair Whitening a Predictor of Hypertension for Healthy Young and Middle-Aged Men?
Abstract
Materials and Methods: A total of 172 healthy males with different stages of hair whitening were included in the study and evaluated after an average of 86 months. During the follow-up, we compared the data of patients diagnosed with HT to those who remained healthy.
Results: Fifty-five (32%) of 172 patients were diagnosed with HT during follow-up period. In terms of demographic characteristics, age (41.48 ± 6.39 vs 44.36 ± 5.25 years; p=0.013), waist circumference (97.52 ± 10.87 vs 104.80 ± 11.94 cm; p=0.004), and body-mass index (27.61 ± 3.56 vs 30.20 ± 3.55 kg/m2; p<0,001) were higher in the HT group, whereas smoking history (p=0.211) was similar between the groups. In univariate analysis carotid intima-media thickness (CIMT)(p=0.013), gamma-glutamyl transferase (GGT)(p=0.021), and uric acid (p<0.001) levels were higher in the HT group; on the contrary, estimated glomerular filtration rate (eGFR)(p=0.039) and high-density lipoprotein (HDL) levels (p=0.026) were lower in this group. There was no difference between groups in terms of hair whitening stage and intensity. In multivariate analysis age (OR=0.143, 95%CI (1.002-1.328), p=0.046), eGFR (OR= -0.058, 95%CI (0.895-0.995), p=0.032), uric acid (OR=0.567, 95%CI (1.032-3.015), p=0.038), GGT (OR=0.030, 95%CI (1.001-1.060), p=0.041), and HDL (OR=-0.129, 95%CI (0.783- 0.986), p=0.028) were independently associated with de nova HT. Body-mass index, CIMT, and the leukocyte count were similar between the groups.
Conclusion: Premature hair whitening is not predictive in determining the development of HT in young and middle-aged healthy men.
Keywords
References
- 1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. PMID: 15364185
- 2. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39(33):3021-104. PMID: 30165516
- 3. González J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: New insights. World J Cardiol 2014;6(6):353-66. PMID: 24976907 4. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71:247-58. PMID: 16765337
- 5. Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension. J Cardiovasc Pharmacol 2003;42:453-61. PMID: 14508229
- 6. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation. Pathogenesis of hypertension and therapeutic aspects. Circ J 2010;74:827-35. PMID: 20424336
- 7. Mazzali M, Kanbay M, Segal MS, Shafiu M, Jalal D, Feig DI, et al. Uric acid and hypertension: cause or effect? Curr Rheumatol Rep 2010;12(2):108-17. PMID: 20425019
- 8. Onat A, Can G, Ornek E, Cicek G, Ayhan E, et al. Serum gamma-glutamyl transferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity (Silver Spring) 2012;20:842-8. PMID: 21633402
- 9. Trüeb RM. Oxidative Stress in Ageing of Hair. Int J Trichology 2009;1(1):6-14. PMID: 20805969
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Ali Gokhan Ozyildiz
*
Türkiye
Mustafa Çetin
0000-0001-6342-436X
Türkiye
Savaş Özer
0000-0002-7073-4021
Türkiye
Hüseyin Durak
0000-0002-8248-5966
Türkiye
Turan Erdoğan
0000-0003-2986-5457
Türkiye
Publication Date
June 15, 2020
Submission Date
April 3, 2020
Acceptance Date
May 27, 2020
Published in Issue
Year 2020 Volume: 10 Number: 2